Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

By Mourad Yasser   Taher Ali   Chehal Aref   Shamseddine Ali  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 319-321

Springer Publishing Company

Access to resources Recommend Favorite

Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab

By Pickartz T.   Ringel F.   Wedde M.   Renz H.   Klein A.   von Neuhoff N.   Dreger P.   Kreuzer K.A.   Schmidt C.A.   Srock S.   Schoeler D.   Schriever F.  

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1410-1416

Elsevier

Access to resources Recommend Favorite

Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 8, Iss. 3, 2008-09 ,pp. : 222-234

Bentham Science Publishers

Access to resources Recommend Favorite

Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse

By Liu E.   Moriyama H.   Paronen J.   Abiru N.   Miao D.   Yu L.   Taylor R.M.   Eisenbarth G.S.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite

Anti-cd20 antibodies to treat lymphoproliferative syndromes following renal transplantation

By Abderrahim E.   Karoui C.   Smaoui W.   Raies L.   Ben Abdallah T.   Hedri H.   Ben Moussa F.   Bardi R.   Ayed K.   Maiz H.B.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2708-2709

Elsevier

Access to resources Recommend Favorite